aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with CKD-MBD in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, Y; Kanagawa, S; Yosikawa, Y | 1 |
1 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and CKD-MBD
| Article | Year |
|---|---|
[Phosphate binders for therapy of hyperphosphatemia causing secondary hyperparathyroidism and renal osteodystrophy in patients with chronic renal failure].
Topics: Acetates; Acetic Acid; Allantoin; Aluminum Hydroxide; Bicarbonates; Chronic Kidney Disease-Mineral and Bone Disorder; Citrates; Citric Acid; Drug Combinations; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium Hydroxide; Phosphates | 1991 |